Biobank Healthy Volunteer Program
Summary
Currently the Biobank of the Molecular Classification of Kidney Disease (BMCKD) is a fully operational biobank operating in both clinical and research capacities. The BMCKD collects, processes, stores, and transfers biospecimens from patients who have evidence or diagnoses of kidney disease.
As the BMCKD continues to expand the size of its repository, it becomes increasingly important to collect biospecimens from healthy volunteers in order to provide healthy control groups for comparative analysis to support future research projects in precise diagnostic testing and genetic studies. Participants provide a ONE TIME donation of blood and urine which will be de-identified.
Eligibility
Eligible ages: 0 to 100
Accepts healthy participants: Yes
Inclusion criteria:
Participants must be:
a) > 18 years of age
b) Healthy [absence of serious co-morbidities including cardiovascular disease, diabetes, obesity (BMI > 30), hypertension, systemic or infectious disease]
c) Normal kidney function (eGFR > 60) or no knowledge of kidney dysfunction
d) Normal urinalysis
Exclusion criteria:
a. Prior immunosuppression eg. steroids
b. Pregnancy
c. Not healthy [presence of serious co-morbidities including cardiovascular disease, diabetes, obesity (BMI > 30), hypertension, systemic or infectious disease]
d. Abnormal kidney function (eGFR < 60) or knowledge of kidney problems
e. Proteinuria > 200mg/d or albumin creatinine ratio > 3.4 mg/mml or dipstick positive for protein
f. Unable to fully disclose smoking status, prior medical complications, medications
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
If you would like to learn more, please contact Graciela Andonegui at andonegu@ucalgary.ca
Principal investigator:
Daniel Abraham Muruve
Clinical trial:
No
REB-ID:
REB16-0622